0.89 Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead: Report

News


<< back

Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead: Report
Date: 2024-05-10 [news.yahoo.com]

READ THE FULL NEWS >>
×